Evaluation of individuals with pulmonary nodules: When is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Gould, Michael K ^a   Donington, Jessica ^b   Lynch, William R ^c   Mazzone, Peter J ^d   Midthun, David E ^e   Naidich, David P ^b   Wiener, Renda Soylemez ^f,g  

^a KAISER PERMANENTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE;

ANATOMIC LANDMARK; ARTICLE; BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOCTOR PATIENT RELATION; ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY; EVALUATION RESEARCH; FALSE NEGATIVE RESULT; FUNCTIONAL ASSESSMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG CANCER; LUNG NODULE; LUNG RESECTION; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT PREFERENCE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; SYSTEMATIC REVIEW; THORACOSCOPY; THORAX RADIOGRAPHY; TRANSTHORACIC BIOPSY; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME; VIRTUAL BRONCHOSCOPY NAVIGATION; VOLUMETRY;

EID: 84877669189     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2351     Document Type: Article

References (185)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): 41S-50S.
2. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003; 348 (25): 2535-2542.
3. Tuddenham WJ. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol. 1984; 143 (3): 509-517.
4. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): e142S-e165S.
5. Schünemann HJ, Oxman AD, Brozek J, et al; GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008; 336 (7653): 1106-1110.
6. published correction in BMJ. 2008;336(7654)
7. Gould MK, Fletcher J, Iannettoni MD, et al; American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidencebased clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):108S-130S.
8. Good CA. Management of patient with solitary mass in lung. Chic Med Soc Bull. 1953; 55 : 893-896.
9. Good CA, Wilson TW. The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years. J Am Med Assoc. 1958; 166 (3): 210-215.
10. Siegelman SS, Khouri NF, Scott WW Jr, et al. Pulmonary hamartoma: CT findings. Radiology. 1986; 160 (2): 313-317.
11. Siegelman SS, Khouri NF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA. Solitary pulmonary nodules: CT assessment. Radiology. 1986; 160 (2): 307-312.
12. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: a cooperative study. Radiology. 1986; 160(2): 319-327.
13. Zwirewich CV, Vedal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation. Radiology. 1991; 179 (2): 469-476.
14. Kishi K, Homma S, Kurosaki A, et al. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer. 2004; 44 (1): 43-51.
15. Seemann MD, Seemann O, Luboldt W, et al. Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCT. Lung Cancer. 2000; 29 (2): 105-124.
16. Woodring JH, Fried AM. Significance of wall thickness in solitary cavities of the lung: a follow-up study. AJR Am J Roentgenol. 1983; 140 (3): 473-474.
17. Harders SW, Madsen HH, Rasmussen TR, Hager H, Rasmussen F. High resolution spiral CT for determining the malignant potential of solitary pulmonary nodules: refining and testing the test. Acta Radiol. 2011; 52 (4): 401-409.
18. Xu DM, van Klaveren RJ, de Bock GH, et al. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. Eur J Radiol. 2008; 68 (2): 347-352.
19. Diederich S, Hansen J, Wormanns D. Resolving small pulmonary nodules: CT features. Eur Radiol. 2005; 15 (10): 2064-2069.
20. Felix L, Serra-Tosio G, Lantuejoul S, et al. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme. Eur J Radiol. 2011; 77 (3): 410-416.
21. Kamiya H, Murayama S, Kakinohana Y, Miyara T. Pulmonary nodules: a quantitative method of diagnosis by evaluating nodule perimeter difference to approximate oval using three-dimensional CT images. Clin Imaging. 2011; 35 (2): 123-126.
22. Mori K, Niki N, Kondo T, et al. Development of a novel computer-aided diagnosis system for automatic discrimination of malignant from benign solitary pulmonary nodules on thin-section dynamic computed tomography. J Comput Assist Tomogr. 2005; 29 (2): 215-222.
23. Berrington de González A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009; 169 (22): 2071-2077.
24. Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009; 169 (22): 2078-2086.
25. Mayo JR, Aldrich J, Müller NL; Fleischner Society. Radiation exposure at chest CT: a statement of the Fleischner Society. Radiology. 2003; 228 (1): 15-21.
26. Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): e166S-e190S.
27. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997; 157 (8): 849-855.
28. Gould MK, Ananth L, Barnett PG; Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007; 131 (2): 383-388.
29. Yonemori K, Tateishi U, Uno H, et al. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology. 2007; 12 (6): 856-862.
30. May BJ, Levsky JM, Godelman A, et al. Should CT play a greater role in preventing the resection of granulomas in the era of PET? AJR Am J Roentgenol. 2011; 196(4): 795-800.
31. Cummings SR, Lillington GA, Richard RJ. Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. Am Rev Respir Dis. 1986; 134(3): 449-452.
32. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology. 1993; 186 (2): 415-422.
33. Copp DH, Godwin JD, Kirby KA, Limaye AP. Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients. Am J Transplant. 2006; 6 (11): 2759-2764.
34. Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18 F-fluorodeoxyglucose positron emission tomography. Chest. 2005; 128 (4): 2490-2496.
35. Isbell JM, Deppen S, Putnam JB Jr, et al. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg. 2011; 91 (1): 227-233.
36. Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008; 63(4): 335-341.
37. Tammemagi MC, Freedman MT, Pinsky PF, et al. Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study. J Thorac Oncol. 2009; 4(6):710-721.
38. Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: Clinical prediction model versus physicians. Mayo Clinic proceedings. Mayo Clinic. 1999; 74(4): 319-329.
39. Gould MK, Simkovich SM, Mestaz PJ, et al. Predicting the probability of malignancy in patients with pulmonary nodules: comparison of clinical judgment with two validated models. Am J Respir Crit Care Med. 2012; 185 : A4425.
40. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC; American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):94S-107S.
41. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000; 214 (1): 73-80.
42. Yamashita K, Matsunobe S, Takahashi R, et al. Small peripheral lung carcinoma evaluated with incremental dynamic CT: radiologic-pathologic correlation. Radiology. 1995; 196 (2): 401-408.
43. Yamashita K, Matsunobe S, Tsuda T, et al. Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. Radiology. 1995; 194 (2): 399-405.
44. Yamashita K, Matsunobe S, Tsuda T, et al. Intratumoral necrosis of lung carcinoma: a potential diagnostic pitfall in incremental dynamic computed tomography analysis of solitary pulmonary nodules? J Thorac Imaging. 1997; 12 (3): 181-187.
45. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microve ssel density. Radiology. 2004; 233 (1): 191-199.
46. Zhang M, Kono M. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology. 1997; 205 (2): 471-478.
47. Bai RJ, Cheng XG, Qu H, Shen BZ, Han MJ, Wu ZH. Solitary pulmonary nodules: comparison of multi-slice computed tomography perfusion study with vascular endothelial growth factor and microvessel density. Chin Med J (Engl). 2009; 122 (5): 541-547.
48. Li Y, Yang ZG, Chen TW, Yu JQ, Sun JY, Chen HJ. Firstpass perfusion imaging of solitary pulmonary nodules with 64-detector row CT: comparison of perfusion parameters of malignant and benign lesions. Br J Radiol. 2010; 83 (993): 785-790.
49. Cronin P, Dwamena BA, Kelly AM, Carlos RC. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology. 2008; 246 (3): 772-782.
50. Grgic A, Yüksel Y, Gröschel A, et al. Risk stratification of solitary pulmonary nodules by means of PET using (18) F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging. 2010; 37 (6): 1087-1094.
51. Kagna O, Solomonov A, Keidar Z, et al. The value of FDGPET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging. 2009; 36 (6): 997-1004.
52. Mizugaki H, Shinagawa N, Kanegae K, et al. Combining transbronchial biopsy using endobronchial ultrasonography with a guide sheath and positron emission tomography for the diagnosis of small peripheral pulmonary lesions. Lung Cancer. 2010; 68 (2): 211-215.
53. Mori T, Nomori H, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol. 2008; 3 (4): 358-364.
54. Ohba Y, Nomori H, Mori T, et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thorac Cardiovasc Surg. 2009; 138 (2): 439-445.
55. Ohba Y, Nomori H, Mori T, Shiraishi K, Namimoto T, Katahira K. Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla. Asian Cardiovasc Thorac Ann. 2011; 19 (2): 108-114.
56. 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med. 2008; 49(2):179-185.
57. Barger RL Jr, Nandalur KR. Diagnostic performance of dual-time 18 F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis. Acad Radiol. 2012; 19 (2): 153-158.
58. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. 2003; 138 (9): 724-735.
59. Berghmans T, Dusart M, Paesmans M, et al; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol. 2008; 3(1):6-12.
60. Nair VS, Barnett PG, Ananth L, Gould MK; Veterans Affairs Solitary Nodule Accuracy Project Cooperative Studies Group. PET scan 18 F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010; 137 (5): 1150-1156.
61. Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol. 2004; 182 (5): 1129-1132.
62. Marom EM, Sarvis S, Herndon JE II, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology. 2002; 223 (2): 453-459.
63. Chang C-Y, Tzao C, Lee S-C, et al. Incremental value of integrated FDG-PET/CT in evaluating indeterminate solitary pulmonary nodule for malignancy. Mol Imaging Biol. 2010; 12 (2): 204-209.
64. Jeong SY, Lee KS, Shin KM, et al. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules. Lung Cancer. 2008; 61 (2): 186-194.
65. Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007; 48 (2): 214-220.
66. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): e211S-e250S.
67. Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality 18 F-FDG PET/CT examinations. J Nucl Med. 2005; 46(4):608-613.
68. Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules. The choice of strategy is a "close call". Am Rev Respir Dis. 1986; 134 (3): 453-460.
69. Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. "What do you mean, a spot?": A qualitative analysis of patients' reactions to discussions with their doctors about pulmonary nodules. Chest. 2013; 143 (3): 672-677.
70. Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 1995; 33 (12): 1176-1187.
71. Geddes DM. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest. 1979; 73(1): 1-17.
72. Weiss W. Tumor doubling time and survival of men with bronchogenic carcinoma. Chest. 1974; 65 (1): 3-8.
73. Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology. 1962; 79 : 221-232.
74. MacMahon H, Austin JH, Gamsu G, et al; Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005; 237 (2): 395-400.
75. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol). 2000; 12 (3): 141-144.
76. Ost DE, Yeung S-J, Tanoue LT, Gould MK. Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2013; 143(5)(suppl): e121S-e141S.
77. Olsson JK, Schultz EM, Gould MK. Timeliness of care in patients with lung cancer: a systematic review. Thorax. 2009; 64 (9): 749-756.
78. Jennings SG, Winer-Muram HT, Tann M, Ying J, Dowdeswell I. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology. 2006; 241 (2): 554-563.
79. Revel MP, Merlin A, Peyrard S, et al. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. AJR Am J Roentgenol. 2006; 187 (1): 135-142.
80. de Hoop B, Gietema H, van de Vorst S, Murphy K, van Klaveren RJ, Prokop M. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology. 2010; 255 (1): 199-206.
81. Korst RJ, Lee BE, Krinsky GA, Rutledge JR. The utility of automated volumetric growth analysis in a dedicated pulmonary nodule clinic. J Thorac Cardiovasc Surg. 2011; 142 (2): 372-377.
82. Jennings SG, Winer-Muram HT, Tarver RD, Farber MO. Lung tumor growth: assessment with CT-comparison of diameter and cross-sectional area with volume measurements. Radiology. 2004; 231 (3): 866-871.
83. Nietert PJ, Ravenel JG, Leue WM, et al. Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest. 2009; 135 (6): 1580-1587.
84. Revel MP, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology. 2004; 231 (2): 453-458.
85. Marchianò A, Calabrò E, Civelli E, et al. Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. Radiology. 2009; 251 (3): 919-925.
86. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009; 136 (6): 1586-1595.
87. Kothary N, Lock L, Sze DY, Hofmann LV. Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin Lung Cancer. 2009; 10 (5): 360-363.
88. Ng YL, Patsios D, Roberts H, et al. CT-guided percutaneous fine-needle aspiration biopsy of pulmonary nodules measuring 10 mm or less. Clin Radiol. 2008; 63 (3): 272-277.
89. Baldwin DR, Eaton T, Kolbe J, et al. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions? Thorax. 2002; 57 (9): 817-822.
90. Wiener RS, Schwartz LM, Woloshin S, Welch HG. Populationbased risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011; 155 (3): 137-144.
91. Mazza E, Maddau C, Ricciardi A, Falchini M, Matucci M, Ciarpallini T. On-site evaluation of percutaneous CT-guided fine needle aspiration of pulmonary lesions. A study of 321 cases. Radiol Med (Torino). 2005; 110 (3): 141-148.
92. Rizzo S, Preda L, Raimondi S, et al. Risk factors for complications of CT-guided lung biopsies. Radiol Med (Torino). 2011; 116 (4): 548-563.
93. Chakrabarti B, Earis JE, Pandey R, et al. Risk assessment of pneumothorax and pulmonary haemorrhage complicating percutaneous co-axial cutting needle lung biopsy. Respir Med. 2009; 103 (3): 449-455.
94. Heyer CM, Reichelt S, Peters SA, Walther JW, Müller KM, Nicolas V. Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates? Acad Radiol. 2008; 15 (8): 1017-1026.
95. Wang HJ, Leung TK, Lee CM, Chen YY. Three-step needle withdrawal method: a modified technique for reducing the rate of pneumothorax after CT-guided lung biopsy. Chang Gung Med J. 2009; 32 (4): 432-437.
96. Guimarães MD, Andrade MQ, Fonte AC, Benevides G, Chojniak R, Gross JL. Predictive complication factors for CT-guided fine needle aspiration biopsy of pulmonary lesions. Clinics (Sao Paulo). 2010; 65 (9): 847-850.
97. Yamagami T, Terayama K, Yoshimatsu R, Matsumoto T, Miura H, Nishimura T. Role of manual aspiration in treating pneumothorax after computed tomography-guided lung biopsy. Acta Radiol. 2009; 50 (10): 1126-1133.
98. Ayyappan AP, Souza CA, Seely J, Peterson R, Dennie C, Matzinger F. Ultrathin fine-needle aspiration biopsy of the lung with transfissural approach: does it increase the risk of pneumothorax? AJR Am J Roentgenol. 2008; 191 (6): 1725-1729.
99. Rivera MP, Mehta AC; American College of Chest Physicians. Initial diagnosis of lung cancer: ACCP evidencebased clinical practice guidelines (2nd edition). Chest. 2007; 132(suppl 3):131S-148S.
100. Naidich DP, Sussman R, Kutcher WL, Aranda CP, Garay SM, Ettenger NA. Solitary pulmonary nodules. CT-bronchoscopic correlation. Chest. 1988; 93 (3): 595-598.
101. Bandoh S, Fujita J, Tojo Y, et al. Diagnostic accuracy and safety of flexible bronchoscopy with multiplanar reconstruction images and ultrafast Papanicolaou stain: evaluating solitary pulmonary nodules. Chest. 2003; 124 (5): 1985-1992.
102. Steinfort DP, Khor YH, Manser RL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J. 2011; 37(4):902-910.
103. Roth K, Eagan TM, Andreassen AH, Leh F, Hardie JA. A randomised trial of endobronchial ultrasound guided sampling in peripheral lung lesions. Lung Cancer. 2011; 74(2): 219-225.
104. Paone G, Nicastri E, Lucantoni G, et al. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions. Chest. 2005; 128 (5): 3551-3557.
105. Schwarz Y, Greif J, Becker HD, Ernst A, Mehta A. Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images: the first human study. Chest. 2006; 129 (4): 988-994.
106. Gildea TR, Mazzone PJ, Karnak D, Meziane M, Mehta AC. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006; 174 (9): 982-989.
107. Eberhardt R, Anantham D, Ernst A, Feller-Kopman D, Herth F. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007; 176 (1): 36-41.
108. Ishida T, Asano F, Yamazaki K, et al; Virtual Navigation in Japan Trial Group. Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial. Thorax. 2011; 66 (12): 1072-1077.
109. Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-Analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 2012; 142 (2): 385-393.
110. Allen MS, Deschamps C, Lee RE, Trastek VF, Daly RC, Pairolero PC. Video-assisted thoracoscopic stapled wedge excision for indeterminate pulmonary nodules. J Thorac Cardiovasc Surg. 1993; 106 (6): 1048-1052.
111. Mack MJ, Hazelrigg SR, Landreneau RJ, Acuff TE. Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann Thorac Surg. 1993; 56(4):825-830.
112. Zaman M, Bilal H, Woo CY, Tang A. In patients undergoing video-assisted thoracoscopic surgery excision, what is the best way to locate a subcentimetre solitary pulmonary nodule in order to achieve successful excision? Interact Cardiovasc Thorac Surg. 2012; 15 (2): 266-272.
113. Marchevsky AM, Changsri C, Gupta I, Fuller C, Houck W, McKenna RJ Jr. Frozen section diagnoses of small pulmonary nodules: accuracy and clinical implications. Ann Thorac Surg. 2004; 78 (5): 1755-1759.
114. Martini N, Ginsberg RJ. Treatment of stage I and stage II disease. Chapter 14. In: Aisner R, Arriga R, Green N, eds. The Comprehensive Textbook of Thoracic Oncology. Baltimore, MD : Williams and Wilkens; 1996 : 338-350.
115. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008; 135 (2): 247-254.
116. Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients. Ann Thorac Surg. 2010; 89 (5): 1563-1570.
117. published correction appears in Ann Thorac Surg. 2011;92(3):1162
118. Paul S, Altorki NK, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010; 139 (2): 366-378.
119. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for TI N0 M0 non-small cell lung cancer. Ann Thorac Surg. 1995; 60 (3): 615-623.
120. Warren WH, Faber LP. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence. J Thorac Cardiovasc Surg. 1994; 107 (4): 1087-1093.
121. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS; ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol. 2002; 178 (5): 1053-1057.
122. Li F, Sone S, Abe H, Macmahon H, Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology. 2004; 233(3): 793-798.
123. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004; 126 (1): 114-121.
124. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002; 165 (4): 508-513.
125. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology. 2004; 231 (1): 164-168.
126. Suzuki K, Nagai K, Yoshida J, et al. Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking. Chest. 1999; 115 (2): 563-568.
127. Benjamin MS, Drucker EA, McLoud TC, Shepard JA. Small pulmonary nodules: detection at chest CT and outcome. Radiology. 2003; 226 (2): 489-493.
128. Piyavisetpat N, Aquino SL, Hahn PF, Halpern EF, Thrall JH. Small incidental pulmonary nodules: how useful is shortterm interval CT follow-up? J Thorac Imaging. 2005; 20 (1): 5-9.
129. Divisi D, Di Tommaso S, Di Leonardo G, Brianzoni E, De Vico A, Crisci R. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Thorac Cardiovasc Surg. 2010; 58 (7): 422-426.
130. Herder GJ, Golding RP, Hoekstra OS, et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2004; 31 (9): 1231-1236.
131. Nomori H, Watanabe K, Ohtsuka T, et al. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004; 128 (3): 396-401.
132. Winer-Muram HT, Jennings SG, Meyer CA, et al. Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations. Radiology. 2003; 229 (1): 184-194.
133. Rusinek H, Naidich DP, McGuinness G, et al. Pulmonary nodule detection: low-dose versus conventional CT. Radiology. 1998; 209 (1): 243-249.
134. Diederich S, Lenzen H. Radiation exposure associated with imaging of the chest: comparison of different radiographic and computed tomography techniques. Cancer. 2000; 89 (suppl 11): 2457-2460.
135. Eisenberg RL, Bankier AA, Boiselle PM. Compliance with Fleischner Society guidelines for management of small lung nodules: a survey of 834 radiologists. Radiology. 2010; 255 (1): 218-224.
136. Wiener RS, Gould MK, Slatore CG, et al. Evaluation of potentially malignant pulmonary nodules in the VA system: resource use and adherence to guideline recommendations. Poster session presented at: VA HSR&D/QUERI National Meeting; July 18, 2012; National Harbor, MD.
137. Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med. 2011; 32 (4): 799-810.
138. Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007; 245 (1): 267-275.
139. Kodama K, Higashiyama M, Takami K, et al. Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. Eur J Cardiothorac Surg. 2008; 34(5):1068-1074.
140. Mun M, Kohno T. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. J Thorac Cardiovasc Surg. 2007; 134 (4): 877-882.
141. Nakata M, Sawada S, Saeki H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003; 75 (5): 1601-1605.
142. Ohtsuka T, Watanabe K, Kaji M, Naruke T, Suemasu K. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Sur. 2006; 30(1):160-163.
143. Carretta A, Ciriaco P, Melloni G, et al. Surgical treatment of multiple primary adenocarcinomas of the lung. Thorac Cardiovasc Surg. 2009; 57 (1): 30-34.
144. Ikeda K, Awai K, Mori T, Kawanaka K, Yamashita Y, Nomori H. Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest. 2007; 132 (3): 984-990.
145. Kim TJ, Goo JM, Lee KW, Park CM, Lee HJ. Clinical, path ological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer. 2009; 64 (2): 171-178.
146. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol. 2003; 180 (3): 817-826.
147. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002; 73 (2): 386-392.
148. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest. 2002; 121 (5): 1464-1467.
149. Park CM, Goo JM, Kim TJ, et al. Pulmonary nodular groundglass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest. 2008; 133 (6): 1402-1409.
150. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6(2):244-285.
151. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology. 2009; 253 (3): 606-622.
152. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004; 45 (1): 19-27.
153. Chun EJ, Lee HJ, Kang WJ, et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer. 2009; 65 (2): 180-186.
154. Raz DJ, Odisho AY, Franc BL, Jablons DM. Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 2006; 132 (5): 1189-1195.
155. Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer. 2002; 38 (3): 261-266.
156. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging. 2002; 29 (9): 1166-1173.
157. 18F]-fluoro-2- deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Lung Cancer. 2010; 69 (2): 187-193.
158. Maeda R, Isowa N, Onuma H, et al. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size. Interact Cardiovasc Thorac Surg. 2009; 9 (1): 70-73.
159. Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg. 2007; 133 (6): 1448-1454.
160. Lee HY, Han J, Lee KS, et al. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings. Lung Cancer. 2009; 66 (3): 379-385.
161. Watanabe K, Nomori H, Ohtsuka T, et al. [F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006; 36 (7): 403-409.
162. Hur J, Lee HJ, Nam JE, et al. Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of groundglass opacity pulmonary lesions. AJR Am J Roentgenol. 2009; 192 (3): 629-634.
163. Shimizu K, Ikeda N, Tsuboi M, Hirano T, Kato H. Percutaneous CT-guided fine needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT. Lung Cancer. 2006; 51 (2): 173-179.
164. Kim TJ, Lee JH, Lee CT, et al. Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol. 2008; 190 (1): 234-239.
165. Infante M, Lutman RF, Imparato S, et al. Differential diagnosis and management of focal ground-glass opacities. Eur Respir J. 2009; 33(4):821-827.
166. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000; 174 (3): 763-768.
167. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000; 73 (876): 1252-1259.
168. Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007; 242 (2): 555-562.
169. Sone S, Nakayama T, Honda T, et al. CT findings of earlystage small cell lung cancer in a low-dose CT screening programme. Lung Cancer. 2007; 56 (2): 207-215.
170. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr. 2004; 28 (1): 17-23.
171. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer. 2004; 44 (1): 61-68.
172. Yoshida J, Nagai K, Yokose T, et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J Thorac Cardiovasc Surg. 2005; 129 (5): 991-996.
173. Ichiki Y, Hanagiri T, Baba T, et al. Limited pulmonary resection for peripheral small-sized adenocarcinoma of the lung. Int J Surg. 2011; 9 (2): 155-159.
174. Ikeda N, Maeda J, Yashima K, et al. A clinicopathological study of resected adenocarcinoma 2 cm or less in diameter. Ann Thorac Surg. 2004; 78 (3): 1011-1016.
175. Koike T, Togashi K, Shirato T, et al. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann Thorac Surg. 2009; 88 (4): 1106-1111.
176. Kondo T, Yamada K, Noda K, Nakayama H, Kameda Y. Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas. Lung Cancer. 2002; 36 (1): 49-57.
177. Okada M, Nishio W, Sakamoto T, Uchino K, Tsubota N. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma. Ann Thorac Surg. 2003; 76(6):1828-1832.
178. Hiramatsu M, Inagaki T, Matsui Y, et al. Pulmonary groundglass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth. J Thorac Oncol. 2008;3(11): 1245-1250.
179. Naidich DP. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013; 266(1):304-317.
180. Kunitoh H, Eguchi K, Yamada K, et al. Intrapulmonary sublesions detected before surgery in patients with lung cancer. Cancer. 1992; 70 (7): 1876-1879.
181. Keogan MT, Tung KT, Kaplan DK, Goldstraw PJ, Hansell DM. The significance of pulmonary nodules detected on CT staging for lung cancer. Clin Radiol. 1993; 48 (2): 94-96.
182. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999; 354 (9173): 99-105.
183. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001; 92 (1): 153-159.
184. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005; 235 (1): 259-265.
185. Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): e369S-e399S.